MetaADEDB 2.0 @ LMMD
ziconotide
(BPKIMPVREBSLAJ-QTBYCLKRSA-N)
Structure
SMILES
NCCCC[C@@H]1NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CSSC[C@H]2C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H]3CSSC[C@H](NC1=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](Cc1ccc(cc1)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N2)CSSC[C@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC3=O)CCCNC(=N)N)CO)CCCCN)C(=O)N)CO)[C@H](O)C
Molecular Formula:
C102H172N36O32S7
Molecular Weight:
2639.130
Log P:
-1.7380
Hydrogen Bond Acceptor:
75
Hydrogen Bond Donor:
42
TPSA:
1310.94
CAS Number(s):
107452-89-1
Synonym(s)
1.
ziconotide
2.
CYS-LYS-GLY-LYS-GLY-ALA-LYS-CYS-SER-ARG-LEU-MET-TYR-ASP-CYS-CYS-THR-GLY-SER-CYS-ARG-SER-GLY-LYS-CYS-NH2
3.
Prialt
4.
SNX 111
5.
SNX-111
6.
leconotide
7.
omega-conopeptide MVIIA
8.
omega-conotoxin M VIIA
9.
omega-conotoxin MVIIA
10.
omega-conotoxin MVIIA, Conus magus
External Link(s)
MeSHC078452
PubChem Compound16135415
102505334
ChEBI135912
CHEMBLCHEMBL2103752
DrugCentral2878
IUPHAR/BPS Guide to PHARMACOLOGY2536
Therapeutic Target DatabaseD01NLB
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1PainFAERS: 6919530373
22084632
CTD
SIDER
US FAERS
2Drug ineffectiveFAERS: 62US FAERS
3NauseaFAERS: 5319530373CTD
SIDER
US FAERS
4DizzinessFAERS: 5019530373CTD
SIDER
US FAERS
5HeadacheFAERS: 42SIDER
US FAERS
6VomitingFAERS: 2519530373CTD
SIDER
US FAERS
7Mental status changesFAERS: 24SIDER
US FAERS
8AmnesiaFAERS: 20SIDER
US FAERS
9Memory impairmentFAERS: 20SIDER
US FAERS
10Burning sensationFAERS: 18SIDER
US FAERS
11AnxietyFAERS: 17SIDER
US FAERS
12AstheniaFAERS: 17SIDER
US FAERS
13MalaiseFAERS: 17US FAERS
14AgitationFAERS: 15SIDER
US FAERS
15Feeling abnormalFAERS: 14SIDER
US FAERS
16Urinary RetentionFAERS: 1419530373CTD
SIDER
US FAERS
17Weight decreasedFAERS: 14SIDER
US FAERS
18Back PainFAERS: 13SIDER
US FAERS
19InfectionFAERS: 13SIDER
US FAERS
20SeromaFAERS: 13US FAERS
21AphasiaFAERS: 12SIDER
US FAERS
22FatigueFAERS: 12SIDER
US FAERS
23TinnitusFAERS: 12SIDER
US FAERS
24DisorientationFAERS: 10SIDER
US FAERS
25DysgeusiaFAERS: 10SIDER
US FAERS
26HypersensitivityFAERS: 10SIDER
US FAERS
27ParanoiaFAERS: 10SIDER
US FAERS
28PneumoniaFAERS: 10US FAERS
29SomnolenceFAERS: 10SIDER
US FAERS
30TremorFAERS: 10SIDER
US FAERS
31Blood creatine phosphokinase increasedFAERS: 9SIDER
US FAERS
32ConstipationFAERS: 9SIDER
US FAERS
33DysarthriaFAERS: 9SIDER
US FAERS
34MeningitisFAERS: 9SIDER
US FAERS
35SwellingFAERS: 9US FAERS
36Unevaluable eventFAERS: 9US FAERS
37Unresponsive to stimuliFAERS: 9US FAERS
38DehydrationFAERS: 8US FAERS
39Peripheral swellingFAERS: 8SIDER
US FAERS
40PruritusFAERS: 8SIDER
US FAERS
41VertigoFAERS: 8SIDER
US FAERS
42CryingFAERS: 7US FAERS
43Mental impairmentFAERS: 7US FAERS
44MyalgiaFAERS: 7SIDER
US FAERS
45No adverse eventFAERS: 7US FAERS
46Urinary tract infectionFAERS: 7US FAERS
47Chest PainFAERS: 6SIDER
US FAERS
48DeliriumFAERS: 6SIDER
US FAERS
49Musculoskeletal stiffnessFAERS: 6US FAERS
50Neck PainFAERS: 6SIDER
US FAERS
51NervousnessFAERS: 6SIDER
US FAERS
52OverdoseFAERS: 6US FAERS
53Psychiatric symptomFAERS: 6US FAERS
54Abdominal PainFAERS: 5SIDER
US FAERS
55ChillsFAERS: 5SIDER
US FAERS
56Completed SuicideFAERS: 5US FAERS
57Drug withdrawal syndromeFAERS: 5US FAERS
58Feeling ColdFAERS: 5US FAERS
59Implant site infectionFAERS: 5US FAERS
60Visual ImpairmentFAERS: 5SIDER
US FAERS
61AbasiaFAERS: 4US FAERS
62Acute psychosisFAERS: 4US FAERS
63AlopeciaFAERS: 4US FAERS
64AngerFAERS: 4US FAERS
65BedriddenFAERS: 4US FAERS
66Catheter related complicationFAERS: 4US FAERS
67Cold sweatFAERS: 4US FAERS
68DiplopiaFAERS: 4SIDER
US FAERS
69DysuriaFAERS: 4SIDER
US FAERS
70FormicationFAERS: 4US FAERS
71Incorrect dose administeredFAERS: 4US FAERS
72LethargyFAERS: 4SIDER
US FAERS
73Maternal exposure during pregnancyFAERS: 4US FAERS
74Perineal painFAERS: 4US FAERS
75Abdominal discomfortFAERS: 3US FAERS
76Activities of daily living impairedFAERS: 3US FAERS
77Acute kidney injuryFAERS: 3US FAERS
78Adverse eventFAERS: 3US FAERS
79AgeusiaFAERS: 3SIDER
US FAERS
80ArthralgiaFAERS: 3SIDER
US FAERS
81AtaxiaFAERS: 319530373CTD
SIDER
US FAERS
82BlindnessFAERS: 3US FAERS
83CellulitisFAERS: 3US FAERS
84Cerebrovascular accidentFAERS: 3SIDER
US FAERS
85Chest discomfortFAERS: 3US FAERS
86Clostridium difficile infectionFAERS: 3US FAERS
87Conversion disorderFAERS: 3US FAERS
88DementiaFAERS: 3US FAERS
89Depressed moodFAERS: 3US FAERS
90Device breakageFAERS: 3US FAERS
91Device dislocationFAERS: 3US FAERS
92ErythemaFAERS: 3US FAERS
93Flank PainFAERS: 3US FAERS
94Implant site extravasationFAERS: 3US FAERS
95Incision site complicationFAERS: 3US FAERS
96IncoherentFAERS: 3US FAERS
97Medication ErrorFAERS: 3US FAERS
98Mood swingsFAERS: 3US FAERS
99Pulmonary EmbolismFAERS: 3US FAERS
100Restless Legs SyndromeFAERS: 3US FAERS
101RhabdomyolysisFAERS: 3SIDER
US FAERS
102ScreamingFAERS: 3US FAERS
103SepsisFAERS: 3SIDER
US FAERS
104SinusitisFAERS: 3SIDER
US FAERS
105Suicide attemptFAERS: 3SIDER
US FAERS
106Therapy changeFAERS: 3US FAERS
107TrismusFAERS: 3US FAERS
108Urinary IncontinenceFAERS: 3SIDER
US FAERS
109nervous system disorderFAERS: 3SIDER
US FAERS
110Accidental overdoseFAERS: 2US FAERS
111Altered state of consciousnessFAERS: 2SIDER
US FAERS
112AngioedemaFAERS: 2SIDER
US FAERS
113AnorexiaFAERS: 2SIDER
US FAERS
114AphagiaFAERS: 2US FAERS
115ArthropathyFAERS: 2US FAERS
116Blood glucose increasedFAERS: 2US FAERS
117Blood sodium decreasedFAERS: 2US FAERS
118Bone painFAERS: 2US FAERS
119BradycardiaFAERS: 2US FAERS
120Breakthrough PainFAERS: 2US FAERS
121Cardiac ArrestFAERS: 2US FAERS
122Catheter related infectionFAERS: 2US FAERS
123CholecystitisFAERS: 2US FAERS
124Concomitant disease progressionFAERS: 2US FAERS
125DiscomfortFAERS: 2US FAERS
126Disease ProgressionFAERS: 2US FAERS
127DysphemiaFAERS: 2US FAERS
128DysphoniaFAERS: 2US FAERS
129Emotional distressFAERS: 2US FAERS
130Hallucinations, mixedFAERS: 2US FAERS
131Head discomfortFAERS: 2US FAERS
132HostilityFAERS: 2SIDER
US FAERS
133HypersomniaFAERS: 2US FAERS
134HypophagiaFAERS: 2US FAERS
135HypotensionFAERS: 2SIDER
US FAERS
136Impaired driving abilityFAERS: 2US FAERS
137Implant site painFAERS: 2US FAERS
138Incorrect route of drug administrationFAERS: 2US FAERS
139LeukocytosisFAERS: 2US FAERS
140Limb discomfortFAERS: 2US FAERS
141Medical device complicationFAERS: 2US FAERS
142MonoparesisFAERS: 2US FAERS
143Myocardial InfarctionFAERS: 2US FAERS
144MyoclonusFAERS: 2US FAERS
145MyositisFAERS: 2SIDER
US FAERS
146NasopharyngitisFAERS: 2US FAERS
147NephrectomyFAERS: 2US FAERS
148NeuralgiaFAERS: 2US FAERS
149Personality ChangeFAERS: 2US FAERS
150PoisoningFAERS: 2US FAERS
151Post procedural complicationFAERS: 2US FAERS
152Post procedural infectionFAERS: 2US FAERS
153Respiratory arrestFAERS: 2US FAERS
154RestlessnessFAERS: 2US FAERS
155RetchingFAERS: 2US FAERS
156Rheumatoid ArthritisFAERS: 2US FAERS
157Skin UlcerFAERS: 2SIDER
US FAERS
158StomatitisFAERS: 2US FAERS
159StressFAERS: 2US FAERS
160Therapeutic response unexpectedFAERS: 2US FAERS
161Toxicity to various agentsFAERS: 2US FAERS
162UrticariaFAERS: 2US FAERS
163Wrong technique in product usage processFAERS: 2US FAERS
164prostatitisFAERS: 2US FAERS
165Abdominal AbscessFAERS: 1US FAERS
166AcarodermatitisFAERS: 1US FAERS
167Accidental deathFAERS: 1US FAERS
168Accidental exposureFAERS: 1US FAERS
169Adjustment disorder with depressed moodFAERS: 1US FAERS
170Administration related reactionFAERS: 1US FAERS
171Alcohol abuseFAERS: 1US FAERS
172Allergy to chemicalsFAERS: 1US FAERS
173Anal spasmFAERS: 1US FAERS
174AnorgasmiaFAERS: 1US FAERS
175AnosmiaFAERS: 1US FAERS
176AphoniaFAERS: 1US FAERS
177ArachnoiditisFAERS: 1US FAERS
178ArteriosclerosisFAERS: 1US FAERS
179Autonomic nervous system imbalanceFAERS: 1US FAERS
180Bacteria urine identifiedFAERS: 1US FAERS
181Bladder dysfunctionFAERS: 1US FAERS
182Blood pressure inadequately controlledFAERS: 1US FAERS
183BradyphreniaFAERS: 1US FAERS
184Brain natriuretic peptide increasedFAERS: 1US FAERS
185Bunion operationFAERS: 1US FAERS
186Burning feet syndromeFAERS: 1US FAERS
187Chest wall painFAERS: 1US FAERS
188ClumsinessFAERS: 1US FAERS
189Coronary artery embolismFAERS: 1US FAERS
190CystitisFAERS: 1US FAERS
191CystFAERS: 1US FAERS
192Depressed Level of ConsciousnessFAERS: 1SIDER
US FAERS
193Device FailureFAERS: 1US FAERS
194Device alarm issueFAERS: 1US FAERS
195Device leakageFAERS: 1US FAERS
196Diabetes MellitusFAERS: 1US FAERS
197DisabilityFAERS: 1US FAERS
198DroolingFAERS: 1US FAERS
199DrowningFAERS: 1US FAERS
200Drug DependenceFAERS: 1US FAERS
201Drug effect incompleteFAERS: 1US FAERS
202DysgraphiaFAERS: 1US FAERS
203DyspepsiaFAERS: 1SIDER
US FAERS
204DysphasiaFAERS: 1US FAERS
205Emotional disorderFAERS: 1US FAERS
206Erectile dysfunctionFAERS: 1US FAERS
207Exposure during breast feedingFAERS: 1US FAERS
208Eye irritationFAERS: 1US FAERS
209Eye painFAERS: 1US FAERS
210Feeling jitteryFAERS: 1SIDER
US FAERS
211Fibrin D dimer increasedFAERS: 1US FAERS
212FlushingFAERS: 1US FAERS
213GamblingFAERS: 1US FAERS
214Gastric BypassFAERS: 1US FAERS
215Gastrointestinal motility disorderFAERS: 1US FAERS
216Gingival AtrophyFAERS: 1US FAERS
217Gingival blisterFAERS: 1US FAERS
218HemiparesisFAERS: 1US FAERS
219HemiplegiaFAERS: 1US FAERS
220HerniaFAERS: 1US FAERS
221Hospice CareFAERS: 1US FAERS
222HydrocephalusFAERS: 1US FAERS
223HyperacusisFAERS: 1US FAERS
224HyperchlorhydriaFAERS: 1US FAERS
225HypokinesiaFAERS: 1US FAERS
226Implant site cellulitisFAERS: 1US FAERS
227Implant site dischargeFAERS: 1US FAERS
228Implant site effusionFAERS: 1US FAERS
229Implant site erosionFAERS: 1US FAERS
230Implant site reactionFAERS: 1US FAERS
231Implant site swellingFAERS: 1US FAERS
232Implant site warmthFAERS: 1US FAERS
233Inappropriate affectFAERS: 1US FAERS
234Inappropriate schedule of drug administrationFAERS: 1US FAERS
235Incision site infectionFAERS: 1US FAERS
236Incision site swellingFAERS: 1US FAERS
237InflammationFAERS: 1US FAERS
238Injection Site ReactionFAERS: 1US FAERS
239Intervertebral Disc DegenerationFAERS: 1US FAERS
240Intervertebral disc disorderFAERS: 1US FAERS
241Intracranial HypotensionFAERS: 1US FAERS
242Joint injuryFAERS: 1US FAERS
243Joint swellingFAERS: 1US FAERS
244Limb injuryFAERS: 1US FAERS
245Malignant neoplasm progressionFAERS: 1US FAERS
246Medical device implantationFAERS: 1US FAERS
247Medical device site swellingFAERS: 1US FAERS
248Mental status changes postoperativeFAERS: 1US FAERS
249Micturition frequency decreasedFAERS: 1US FAERS
250Middle insomniaFAERS: 1US FAERS
251MoaningFAERS: 1US FAERS
252Multi-organ disorderFAERS: 1US FAERS
253Multiple drug therapyFAERS: 1US FAERS
254Muscle SpasticityFAERS: 1US FAERS
255Muscle tightnessFAERS: 1US FAERS
256Musculoskeletal PainFAERS: 1US FAERS
257Musculoskeletal discomfortFAERS: 1SIDER
US FAERS
258MyocarditisFAERS: 1US FAERS
259NephrolithiasisFAERS: 1US FAERS
260Nerve injuryFAERS: 1US FAERS
261Neuroleptic Malignant SyndromeFAERS: 1US FAERS
262NeuromaFAERS: 1US FAERS
263ObesityFAERS: 1US FAERS
264OnychoclasisFAERS: 1US FAERS
265Oral mucosal exfoliationFAERS: 1US FAERS
266Oral painFAERS: 1US FAERS
267Oropharyngeal plaqueFAERS: 1US FAERS
268OsteoporosisFAERS: 1US FAERS
269Paranasal sinus discomfortFAERS: 1US FAERS
270ParaparesisFAERS: 1US FAERS
271ParaplegiaFAERS: 1US FAERS
272Pelvic PainFAERS: 1US FAERS
273Peripheral arterial occlusive diseaseFAERS: 1US FAERS
274PetechiaeFAERS: 1US FAERS
275Pharmaceutical product complaintFAERS: 1US FAERS
276Physical assaultFAERS: 1US FAERS
277Pre-existing condition improvedFAERS: 1US FAERS
278PseudomeningoceleFAERS: 1US FAERS
279Quality of life decreasedFAERS: 1US FAERS
280Radicular painFAERS: 1US FAERS
281Rash erythematousFAERS: 1US FAERS
282Renal painFAERS: 1US FAERS
283Respiratory distressFAERS: 1SIDER
US FAERS
284SciaticaFAERS: 1US FAERS
285Septic ShockFAERS: 1US FAERS
286Serum SicknessFAERS: 1US FAERS
287Sexual DysfunctionFAERS: 1US FAERS
288Sick Sinus SyndromeFAERS: 1US FAERS
289Sinus TachycardiaFAERS: 1US FAERS
290Skin discomfortFAERS: 1US FAERS
291SluggishnessFAERS: 1US FAERS
292SneezingFAERS: 1US FAERS
293Somatic symptom disorderFAERS: 1US FAERS
294Spinal column stenosisFAERS: 1US FAERS
295Spinal cord infectionFAERS: 1US FAERS
296SpondylolisthesisFAERS: 1US FAERS
297StaringFAERS: 1US FAERS
298StenosisFAERS: 1US FAERS
299SyncopeFAERS: 1US FAERS
300TensionFAERS: 1SIDER
US FAERS
301Therapeutic response changedFAERS: 1US FAERS
302Thermal burnFAERS: 1US FAERS
303ThirstFAERS: 1US FAERS
304ThrombosisFAERS: 1US FAERS
305Tooth LossFAERS: 1US FAERS
306ToothacheFAERS: 1US FAERS
307TracheobronchitisFAERS: 1US FAERS
308Transaminases increasedFAERS: 1US FAERS
309Urinary hesitationFAERS: 1SIDER
US FAERS
310Vibratory sense increasedFAERS: 1US FAERS
311Vulvovaginal burning sensationFAERS: 1US FAERS
312White blood cell count decreasedFAERS: 1US FAERS
313Wound InfectionFAERS: 1US FAERS
314Wound infection staphylococcalFAERS: 1US FAERS
315Anxiety aggravatedSIDER
316Aspartate Aminotransferase IncreasedSIDER
317Atrial FibrillationSIDER
318Blood creatine phosphokinase MM increasedSIDER
319Confusion aggravatedSIDER
320Confusion19530373CTD
321Depression aggravatedSIDER
322DermatitisSIDER
323Drug Overdose19530373CTD
324Ear and labyrinth disordersSIDER
325Electrocardiogram abnormalSIDER
326Gait Disorders, Neurologic19530373CTD
327Gastrointestinal PainSIDER
328Hallucinations19530373CTD
329HyporeflexiaSIDER
330Hypotension, Orthostatic19530373CTD
331InfestationSIDER
332MalnutritionSIDER
333Mental RetardationSIDER
334MyopathySIDER
335Nausea aggravatedSIDER
336NystagmusSIDER
337Pain worsenedSIDER
338Pain, Intractable20439438CTD
339PhotophobiaSIDER
340Poor quality sleepSIDER
341StuporSIDER
342Visual disturbanceSIDER
343WakefulnessSIDER
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120235

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.